LARIMAR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.38 USD | -0.67% |
|
+3.65% | +62.20% |
| May. 09 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 09 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-14 | 2024-05-15 | 2024-05-16 | 2024-05-17 | |
|---|---|---|---|---|
| Last | 7.88 $ | 7.87 $ | 7.43 $ | 7.38 $ |
| Volume | 328 292 | 165 636 | 465 595 | 284 266 |
| Change | +7.65% | -0.13% | -5.59% | -0.67% |
| Opening | 7.43 | 8.01 | 7.91 | 7.44 |
| High | 8.11 | 8.09 | 8.11 | 7.48 |
| Low | 7.43 | 7.82 | 7.34 | 7.23 |
Performance
| 1 day | -0.67% | ||
| 1 week | +3.65% | ||
| Current month | +7.11% | ||
| 1 month | +13.02% | ||
| 3 months | -42.25% | ||
| 6 months | +124.32% | ||
| Current year | +62.20% | ||
| 1 year | +101.64% | ||
| 3 years | -39.46% |
Volumes
marketsDaily volume
284 266
Estimated daily volume
284 266
Avg. Volume 20 sessions
275 528
Daily volume ratio
1.03
Avg. Volume 20 sessions USD
2 033 396.64
Record volume 1
9 144 908
Record volume 2
6 092 399
Record volume 3
5 063 141
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
470 858 885
Net sales (USD)
0
Number of employees
42
Sales / Employee (USD)
0
Free-Float
98.55 %
Free-Float capitalization (USD)
464 030 127
Average Daily Capital Traded
0.43%
Highs and lows
1 week
7.23
8.11
1 month
5.918.33
Current year
4.0913.68
1 year
2.1813.68
3 years
1.5315.49
5 years
1.5325.87
10 years
1.5325.87
Indicators
Moving average 5 days
7.58
Moving average 20 days
7.23
Moving average 50 days
7.64
Moving average 100 days
7.46
Price spread / (MMA5)
+2.66%
Price spread / (MMA20)
-2.02%
Price spread / (MMA50)
+3.55%
Price spread / (MMA100)
+1.12%
STIM
RSI 9 days
48.82
RSI 14 days
49.31
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.67% | +3.65% | +62.20% | +101.64% | 471M | ||
| +1.04% | +5.31% | +9.42% | +30.29% | 115B | ||
| +1.48% | +0.87% | +11.84% | +29.41% | 106B | ||
| -1.56% | -2.22% | -2.59% | -14.27% | 21.96B | ||
| -2.55% | -1.16% | -14.15% | -14.91% | 21.87B | ||
| +0.74% | +1.90% | -5.29% | -27.68% | 19.21B | ||
| +1.06% | +7.27% | -4.16% | -25.69% | 18.08B | ||
| -1.49% | +0.11% | -38.29% | -33.18% | 17.71B | ||
| +0.27% | +4.09% | +7.99% | +51.28% | 14.32B | ||
| -1.02% | -0.33% | +36.24% | -11.88% | 12.42B | ||
| -2.61% | +4.44% | -24.95% | -35.24% | 8.23B | ||
| -1.17% | +14.39% | +18.74% | +54.61% | 8.11B | ||
| -0.59% | -0.21% | -0.71% | +29.70% | 7.67B | ||
| -0.14% | -0.71% | -52.57% | -68.48% | 7.49B | ||
| -3.03% | -9.02% | +260.02% | +191.68% | 7.39B | ||
| -1.37% | -9.25% | -3.83% | +34.00% | 6.95B | ||
| Average | -0.70% | +0.80% | +16.24% | +18.20% | ||
| Weighted average by Cap. | -0.24% | +2.01% | +8.02% | +16.62% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
82cd449ef5b0191c0a71d5c7b14.WnTTiFsv5B03jUP_2hC4Ej7mM5D8oPo6lEHTf9-T-ew.CwK2yQl1lCVtvyGUt0joJ1bLdKHFlswL5QiMNbDqn6cZOoK5OF7SUES7IA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 7.38 | 30,356 | 227,440 |
| 03:59:54 pm | 7.39 | 100 | 197,084 |
| 03:59:50 pm | 7.39 | 355 | 196,984 |
| 03:59:50 pm | 7.39 | 100 | 196,629 |
| 03:59:50 pm | 7.39 | 100 | 196,529 |
| 03:59:49 pm | 7.38 | 100 | 196,429 |
| 03:59:48 pm | 7.39 | 100 | 196,329 |
| 03:59:47 pm | 7.39 | 100 | 196,229 |
| 03:59:46 pm | 7.39 | 100 | 196,129 |
| 03:59:46 pm | 7.38 | 100 | 196,029 |
Monthly variations
Annual change
| 2024 | +62.20% | ||
| 2023 | +10.17% | ||
| 2022 | -61.72% | ||
| 2021 | -49.60% | ||
| 2020 | +74.07% |
- Stock Market
- Equities
- LRMR Stock
- Quotes Larimar Therapeutics, Inc.
